Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$GTHP I see this as a buying opp to average in now (didn't get in earlier)
Agree with earlier statement that the FDA would probably have nixed things already if it were a complete no-go.
March catalyst could be FDA's delayed PMA, and (maybe more significantly),
"the Company anticipates providing sales guidance for the upcoming year in March 2015 when it reports its results for the year ended December 31, 2014.
The Company currently has regulatory approval to sell LuViva in Europe with the Edition 3 CE mark, and has marketing approvals from COFEPRIS in Mexico, Health Canada and Singapore Health Sciences Authority, among others. Additionally, expansion efforts are ongoing in the Middle East, Asia and Latin America."
______________________________
$GTHP- thanks. Was on my watch list.
Just got a few at .18 and on that bid for more.
There's seller at .185 that I hope dumps.
$ZGNX- seems oversold now. Re-entering at $1.24
But will dump in a heartbeat if it drops under $1.20!
Zogenix will be initiating the next phase of studies for Relday, a once/month subcutaneous injection for persons suffering from schizophrenia in Q1 of this year.
Phase I trials of Relday were positive and if approved, Relday will be the first subcutaneous antipsychotic product that allows for once-monthly dosing.
$BIAD The potential for this one to tutn EPS + soon is there.
Cash burn is now down to $70K/month and influx of $1M from Sysmex should be counted as either deferred revenue or current revenue. Because they actually received the cash in Q1, I'd say it will be recorded as current and with no debt, zero dilution, and cash burn of 70K/month, that will have a big impact on the fundamentals.
That's why I see it as far less risky than most nanocaps and why (I believe) DueDiligence allowed me to post about it here.
But so we're not cluttering the board here with BIAD, please check out the BIAD board for more information: Bio-AMD I-hub
These analysts that fall all over themselves telling us to buy DDD and SSYS at crazy highs in the fall of 2013 are now telling everyone to sell them, and the BEST performing OEM YTD that's got the organic growth they whine about DDD and SSYS not having is Arcam.
You would think at some point they start to pound the table just a little on the stock.
Changed to include:
This is offset by $9.3 MSEK in non-recurring costs, for a net of ~ $6.5 MSEK towards earnings.
Let me know if there's an easier/more understandable way to put it.
And thank you for the editorial help! Much appreciated when I'm only on my second cup of coffee...
I did currency conversions (which I wish Arcam would do in their press releases!) to USD.
https://3dprintingstocks.com/arcam-2014/
$MEIP - chart
Coming off bottom of bollingerband range, support found again today at 10 dma. Sure looks like bottom in place- but who knows. Like $heff, I don't like the way it trades- but have been adding and looking forward to March catalyst. I hope to see close above $4 in next week to really confirm bottom.
Microcap $BIAD zero debt, zero dilution, $1M + revenues (up from zero) & undiscovered
I received permission from DewDiligence to post about Bio-AMD (BIAD) here.
This stock is definitely not for everyone due to being pretty much unknown and thinly traded, but I believe BIAD will be commercializing their hand-held blood COAG measurement device next year with Sysmex Corp, a $ 9 billion biotech company with a strong presence in Europe and Asia.
If you have a high risk tolerance and a 6-12 month horizon, BIAD might be appropriate for you- but it is still a high risk investment.
The company bought the technology out of bankruptcy and I believe shareholders will reap the rewards when it's commercialized. Questcor comes to mind- although that's an extreme example I cite in the article.
More on BIAD in my article here: Why Bio-AMD (BIAD) Shares are Poised to Move Higher
With Fundamentals in focus (as they should be) I have to think Arcam will be standing out in the coming days/weeks based on organic growth rate, lack of dilution, etc. Too many mainstream publications only cover DDD, SSYS, XONE, VJET numbers- that's been changing, although slowly over the last 2 years.
I think the 2014 report and prospects for 2015 will continue to bring awareness to this industry standout.
ARCM.ST is the only pure play 3D printer OEM that's up YTD, and we all know that's because of the company's fundamentals. Here's to more people discovering those fundamentals in the coming days/weeks!
$MEIP- added 3.71
I think a combination of profit taking and shorts. Stock gapped up way too much from sale of just on printer, and folks sold.
Just my guess.
Bought ARCM.ST on SSYS disaster
Arcam should announce a record Q4 and record year in terms of revenue and EPS on Thursday
Article: Graphene-Enhanced 3D Printing Filament is on its Way
http://3dprintingindustry.com/2015/02/02/graphene-enhanced-3d-printing-filament-launch-graphene-3d-lab/
$BIAD article
http://microcapresearch.com/bio-amd-inc/
CAMT News Camtek Receives First Conditional Order for Gryphon - The 3D Functional Inkjet Technology System
http://finance.yahoo.com/news/camtek-receives-first-conditional-order-124000946.html
This is a strong short here IMO.
But I don't have the balls to short it. Float too low and too many probably still wanting to pile in.
Bought/Sold some HABT (sympathy play) and avoided SHAK.
yes.
Check the contact information (same phone number as Graphene 3D Lab) and the domain name is registered to Graphene 3D Lab.
wow- you beat me to it.
I posted a comment that's awaiting moderation at Nanalyze, which reads:
"Agree that “the actual commercialization of graphene products seems to be progressing at a snail’s pace”, and the Zapgocharger looks very compelling to me as an avid i-Phone user…but not at $149. I’m sure they’ll be bought out by someone or get funding to ramp production to levels where they are able to lower the cost.
Additionally, Graphene 3D Lab is going to be commercializing graphene-enhanced filaments (sales to begin by March) according to this news: http://finance.yahoo.com/news/filament-production-equipment-operational-graphene-134200958.html
As far as I know, this will make Graphene 3D Lab1st to market with graphene filaments on any scale. Your earlier article on the company came across (to me anyway) as doubtful that the company would have a commercial launch and/or generate revenue.
I hope after they officially launch their filaments you might publish an update?"
______________
For the record, nanalyze has been wrong (as have I!) in the past. They panned Groupe Gorge a few days after I wrote about it back in December 2013, and the stock doubled since then and has outperformed everything 3D printing-related right up to today. However, they also panned SGLB when it was on fire, and they got that one right due to a very slow roll-out of their products.
A note about the 3D printing stock index
The index I run is simply the combined, weighted market caps for DDD, SSYS, XONE, VJET, ONVO, and AMAVF.
Despite the overall rocky market, the index managed to close up for two consecutive weeks. It was up 5% last week and 0.5% this week, despite a downgrade on DDD.
Early signs of a bottom maybe? Something to keep an eye on.
Have a good weekend folks!
Congrats!
I missed CPRX- but I know there's many more to come here at $Sheff Station!
They have not 3D printed a cell phone.
The quote that the company "has successfully printed a simple cell phone" in Wired mag is inaccurate.
They have 3D printed a working battery and are commercializing graphene-enhanced filaments for 3D printing. This is all public and in their filings.
But they have not 3D printed a cell phone and apparently there will be a correction made in the article on Wired.
$GPHBF - Apparently Wired mag. is incorrect
Graphene 3D Lab has NOT 3D printed a cell phone
Wired Magazine in error- Graphene 3D Lab has NOT 3D printed a cell phone.
https://3dprintingstocks.com/correction-graphene-3d-lab-not-3d-printed-cell-phone/
So mad I could spit: Graphene 3D Lab has NOT 3D printed a cell phone
https://3dprintingstocks.com/correction-graphene-3d-lab-not-3d-printed-cell-phone/
$GPHBF breaking out on news they 3D Printed a Cell Phone
https://3dprintingstocks.com/graphene-3d-lab-phone/
I just got confirmation that this is absolutely true.
They have 3D Printed a Cell Phone- this is completely new news to me. Think they should have a official pr on it. I'm sure it's a prototype of some sort- but the fact they're working on this is pretty amazing IMO.
https://3dprintingstocks.com/graphene-3d-lab-phone/
$GPHBF $GGG.V - Confirmed by my source at the company:
Graphene 3D Lab has 3D printed a cell phone.
I would think it does.
You would have to subscribe to Level II quotes on the exchange.
Doubt you can get it for free.
I'm talking about 3D printing cell phones.
Not prosthetics.
yes
They are talking about the possibilities for graphene's use when combined with 3D printing.
Not current uses.
"could be used to print everything from medical prosthetics to solar cells"
Anyway, the point is, they have 3D printed a simple cell phone- which is pretty amazing.
A typo in name, yes.
3D printing is already widely used in medical prosthetics with FDA approval. In fact, it's one of the fastest-growing areas for 3D printing.
Agree with your point on solar cells.
As for "where the heck is this coming from?", it's coming a division of Wired.com which is a pretty respectable publication.
I just emailed the key investor group in $GPHBF/$GGG.V to confirm
If they can 3D print a simple cell phone, then this stock goes much higher pretty quick.
$GPHBF "3D Printed a Cell Phone"
No pr from company but holy crap! This could be a mover.
See article in Wired.com
http://www.wired.com/campaigns/theconnectivehub/?p=700
Wired.com - The Connective says Graphene 3D Lab "3D printed a simple cell phone"
http://www.wired.com/campaigns/theconnectivehub/?p=700
I need to confirm this- I wonder if they meant they 3D printed a simple battery..which we already know. If they can 3D print even a "simple" cell phone, then why didn't they issue a pr on this?
Graphene 3D Lab "3D printed a simple cell phone" (???)
I just saw this article- I wonder if they meant they 3D printed a simple battery? If Graphene 3D Lab 3D printed a cell phone (even a "simple cell phone"), wouldn't there have been a pr?
http://www.wired.com/campaigns/theconnectivehub/?p=700
$MEIP I like
At current price MEIP is my fav. pharma/.biotech stock with one exception that I can't mention here due to OTC status. :(